UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Proctology — haemorrhoids and perianal skin conditions

Harald Rosen, Janindra Warusavitarne, Nuha Yassin

Summary

AI Generated

This European Society of Coloproctology course by Harald Rosen, Janindra Warusavitarne and Nuha Yassin provides state-of-the-art information on haemorrhoids and perianal skin conditions.

  • The course covers anatomy and physiology of haemorrhoids, classification systems for identifying patients with haemorrhoid problems, and therapeutic management including conservative and surgical approaches.
  • Diagnosis and treatment of the most common dermatologic problems in the anal and perianal area are included in the learning objectives.
  • The target audience includes gastroenterologists and surgeons in training, as well as other physicians, nurses, biotechnicians and medical students with an interest in coloproctology.
  • The material was reviewed and updated in April 2024.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Proctologic disorders are a widespread problem—their high incidence means that many different healthcare professionals (e.g. gastroenterologists, surgeons, dermatologists, nurses, young residents, etc.) will be confronted by patients complaining about a proctologic disease.

This course by European Society of Coloproctology (ESCP) experts Harald Rosen, Janindra Warusavitarne and Nuha Yassin provides the most recent state-of-the-art information on the common proctologic disorders of haemorrhoids and perianal skin conditions.

Learning objectives

  • The anatomy and physiology of haemorrhoids, the most common classification system used to identify patients with problems, and therapeutic management (conservative and surgical) 
  • The diagnosis and treatment of the most common dermatologic problems in the skin of the anal and perianal area 

Target audience

This course is suitable for gastroenterologists and surgeons in training, but is also appropriate for other physicians, as well as nurses, biotechnicians and medical students who have an interest in coloproctology.

Reviewed & updated April 2024

Event

Proctology — haemorrhoids and perianal skin conditions

Topics

Surgery

Accreditation status

accredited

Duration

1 hour

Published

2021

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Presentation
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia 1

Affiliations

1 Fortis hospital, Noida, Noida, India

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Gastric varices are a severe complication of portal hypertension, associated with a high risk of bleeding(1). Conventional endoscopic therapies, including cyanoacrylate injection, are effective but may be limited by risks of embolization and incomplete obliteration.
Endoscopic ultrasound (EUS)-guided therapy has emerged as a precise and targeted modality, allowing real-time visualization of variceal anatomy and hemodynamics. The combination of coil embolization with cyanoacrylate glue enhances treatment efficacy by providing a scaffold for glue retention while minimizing the risk of systemic embolization.(2,3)
However, an important technical question remains unresolved: whether to target the variceal sac directly or to embolize the feeder vessel supplying the varix. The latter, particularly in patterns such as Arakawa-1, may offer a more physiological approach by interrupting inflow at its source.
In this video, we demonstrate and compare these two EUS-guided strategies—direct variceal puncture versus feeder vessel targeting using coil and glue—to highlight their technical nuances and clinical implications.

Aims & Methods

Aims: To compare two EUS-guided strategies for gastric varices—direct variceal puncture versus feeder vessel embolization (Arakawa-1)—using combined coil and cyanoacrylate glue therapy.
Methods: Linear EUS with Doppler was used to delineate variceal anatomy and confirm active blood flow prior to intervention.

  • Technique 1 (Direct variceal approach):
    Under EUS guidance, the varix was directly punctured, followed by deployment of an embolization coil within the variceal lumen. Cyanoacrylate glue was subsequently injected.
  • Technique 2 (Feeder vessel approach – Arakawa-1):
    A feeder vessel supplying the varix was identified using Doppler imaging. The vessel was selectively punctured, followed by coil embolization and glue injection to interrupt inflow.

Procedural steps, technical nuances, and outcomes are presented in a comparative video format.

Results

Both techniques were technically successful. Pre-procedure Doppler confirmed active flow. Post-procedure EUS showed echogenic coil–glue complexes with reduction in variceal lumen, suggesting effective obliteration. The feeder vessel (Arakawa-1) approach required less glue and achieved upstream flow control. No immediate complications were observed.

FeatureDirect Varix ApproachFeeder Vessel (Arakawa-1)
TargetVariceal sacFeeder vessel (source)
MechanismLocal obliterationUpstream flow interruption
Glue neededHigherLower
Control of inflowLimitedBetter
Technical demandSimplerMore precise

Conclusion

EUS-guided coil and glue therapy is effective for gastric varices. Feeder vessel targeting (Arakawa-1) may provide better flow control with less glue compared to direct variceal puncture.

References

1.Tayyem O, Bilal M, Samuel R, Merwat SK. Evaluation and management of variceal bleeding. Disease-a-Month. 2018 Jul 1;64(7):312-20.
2. Romero-Castro R, Ellrichmann M, Ortiz-Moyano C, Subtil-Inigo JC, Junquera-Florez F, Gornals JB, Repiso-Ortega A, Vila-Costas J, Marcos-Sanchez F, Muñoz-Navas M, Romero-Gomez M. EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos). Gastrointestinal endoscopy. 2013 Nov 1;78(5):711-21.
3 Adler DG, Bidani K. Endoscopic Ultrasound-Guided Therapy for Gastric Varices: Current Evidence and Emerging Perspectives. PRACTICAL GASTROENTEROLOGY. 2025 Sep:45.

Event

UEG Week Barcelona 2026

Topics

Endoscopy Oesophagus

Submission format

Video Case

Session

Lights, camera, lumen! High-impact endoscopy video cases

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of early-invasive (T1) colorectal cancer

Alexandra Langers, Jurjen J. Boonstra, James Hardwick

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

With the introduction of population-based screening programs in several countries, the proportion of patients diagnosed with early invasive colorectal cancer (T1 CRC) has been vastly increasing. There are several major challenges in clinical management of this patient group, resulting in significant practice variations among physicians.

This online course covers the most relevant aspects of clinical management of T1 CRC patients, and provides an overview of latest insights and current knowledge gaps. To facilitate the learning process, several questions on real-life patient cases have been included in which learners can bring the acquired knowledge directly into practice.

Learning objectives

  • To systematically assess colorectal lesions and identify those suspicious for submucosally invasive (T1) cancer
  • To learn about local resection techniques for T1 colorectal cancer
  • To gain insight into histological assessment of local en bloc resection specimens of T1 colorectal cancer
  • To be aware of considerations from the oncological and patient perspective in therapeutic decision making after local treatment for T1 colorectal cancer

Target audience

This course is suitable for gastroenterologists, surgeons, pathologists, nurses and any other healthcare professionals interested in, or actively involved in clinical management of T1 CRC patients. 

This course was developed by Alexandra M.J. Langers, Jurjen J. Boonstra, James C.H. Hardwick, Richard (H.) Dang et al. in receipt of an Activity Grant from UEG.

Reviewed & updated December 2022

Event

Management of early-invasive (T1) colorectal cancer

Topics

Digestive Oncology

Accreditation status

accredited

Duration

1 hour

Published

2020

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Gastroenterologist's guide to stem cells

Simon Leedham, Stuart McDonald

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

About this online course

Stem cells are primitive and undifferentiated cells in human tissues (foetal and adult) with self-renewal, multipotency and longevity properties. They are responsible for cellular regeneration within the gastrointestinal tract but also play an essential role in different GI pathologies (e.g., Barrett’s oesophagus).

A gastroenterologist’s guide to stem cells, by Simon Leedham and Stuart McDonalds, covers the basic definitions of stem cells and their different locations in the gastrointestinal tract, homeostasis, the role of stem cells in intestinal regeneration, metaplasia, and tumour heterogeneity. The course includes comprehensive PPT slides, and bespoke video presentations filmed in London in December 2022. Figures, schemes, and further readings are included for consideration. The combined material has a total duration of approximately 60 minutes. The estimated time needed to complete the course, including the final assessment, is 60 minutes.

Target audience

This course is suitable for gastroenterologists in training, but is also appropriate for nurses, basic scientist in gastroenterology, medical students with interest in gastroenterology as well as other physicians (oncology, regenerative medicine, research).

Event

Gastroenterologist's guide to stem cells

Accreditation status

accredited

Duration

1 hour

Published

2024

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Presentation
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Savino Paradiso 1, Guido Carpino 1, Paola Infante 1, Lucia Di Marcotullio 1, Deborah Quaglio 1, Chiara Di Meo 1, MATTEO FRANCHITTO 1, Teresa De Luca 1, Bruno Botta 1, Eugenio Gaudio 1, Domenico Alvaro 1, Vincenzo Cardinale 1

Affiliations

1 Sapienza - University of Rome, Rome, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Cholangiocarcinoma (CCA) comprises a heterogeneous group of cancers affecting the biliary tree and is considered one of the deadliest cancers. CCA incidence and mortality are increasing dramatically worldwide in the last decades. CCA prognosis is dismal (5-year survival rate <20%) due to various aspects including late diagnosis, poor response to chemotherapy and lack of well-established targeted therapeutic options. One of the foremost patho-biological features of CCA is the high inter- and intra-tumoral heterogeneity, which has limited the discovery of biomarkers and novel therapeutic alternatives, hampering the development of tools for early diagnosis and effective treatment, with unfavorable implications on patient outcome. From an anatomical outlook, CCA is classified into intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA). Furthermore, iCCA shows distinct histological subtypes which led the World Health Organization (ICD-O-3.2) to categorize it into small and large bile duct-type. Noteworthy, thus far no data exist concerning the correlation of molecular traits and specific iCCA subtypes. Indeed, this marked heterogeneity strikingly restricts the possibility of translational research and represents an utmost aspect to be scrutinized. The Hedgehog (Hh) pathway is one of the molecular networks involved in the pathogenesis of iCCA. As a matter of fact, it is fundamental in various hallmarks of iCCA, including tumor growth, survival, migration, cancer stem cells activation and epithelial-mesenchymal transition. In the light of these observations, targeting this cascade for therapeutic purposes in iCCA is possible owing to evidence of Hh's pathogenetic role in the disease.

Aims & Methods

This study aims to evaluate, in vitro, in primary and established cell lines, a novel natural chemical compound called Glabrescione B (GlaB) that specifically inhibits Gli1, a transcriptional factor downstream of Hh pathway.
Using Trypan Blue Exclusion test, the dose- and time-dependent response of free GlaB and hyaluronic acid (HA)-encapsulated GlaB (HA-GlaB) has been evaluated. MTS assay has been performed to determine the IC50. Western blot has been used to analyze the target protein expression levels. Wound-healing assay has been achieved to assess the cell migration. Colony formation assay has been performed to rate the colony-forming ability of cancer cells. Flow cytometry analysis has been accomplished to investigate cell death. The results were confirmed in at least three independent experiments and the quantitative data were reported as the mean ± SEM. Student’s t-tests for paired samples were used to assess differences among two groups. A p-value of <0.05 was considered statistically significant (*p<0.05;**p<0.01;***p<0.001).

Results

Our findings demonstrate that both free GlaB and HA-GlaB treatments significantly reduce iCCA cell rate viability, migration, colony-forming ability, and Gli1 levels in a dose- and time-dependent manner (0.05<p<0.001), leading to a decisive decrease in cancer cells invasiveness. Ultimately, compared to controls, early evidence from flow cytometry reveals an induction of necrosis and apoptosis as a result of drug administration.

Conclusion

Hedgehog pathway dysregulation is well known to be correlated with the development and progression of various cancers, including iCCA. A novel natural compound, named Glabrescione B, is able to inhibit cancer cells growth, survival, invasiveness and to induce cancer cell death. Taken together, these data provide insight into a new and potentially beneficial natural compound for the management of iCCA in vivo.

References

1. Banales JM. et al., Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. Epub 2020 Jun 30. PMID: 32606456.
2. Bertuccio P. et al., J Hepatol. 2019 Jul;71(1):104-114. Epub 2019 Mar 23. PMID: 30910538.
3. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL-ILCA Clinical Practice Guidelines on Intrahepatic Cholangiocarcinoma. J Hepatol. 2023 Mar 22:S0168-8278(23)00185-X. Epub ahead of print. PMID: 37084797.
4. Riedlinger D. et al., J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):607-15. Epub 2014 Apr 15. PMID: 24733827.
5. Cigliano A. et al., Expert Opin Ther Targets. 2017 May;21(5):471-483.1310842. Epub 2017 Mar 30. PMID: 28326864.
6. Razumilava N. et al., J Hepatol. 2014 Mar;60(3):599-605. Epub 2013 Nov 14. Erratum in: J Hepatol. 2014 Jul;61(1):185. PMID: 24239776.
7. Infante P, et al., Cancer Lett. 2021 Feb 28;499:220-231. Epub 2020 Nov 26. PMID: 33249196.

Event

UEG Week Vienna 2024

Topics

Digestive Oncology Endoscopy Mechanisms & Personalised Medicine Hepatobiliary

Submission format

Abstract

Session

Diagnose and treat to target in GI cancer: Latest news

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Mary Phillips, Leigh Donnelly

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Primary Care

Published

2025

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

How to develop guidelines - Part 1

Yasuko Maeda, Adele Sayers, Ana Dugic

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Modern guideline development has evolved over the last 20 years to improve quality of clinical guidelines.

This course aims to provide basic knowledge of developing guidelines. It will explain the process of how to go about writing protocol, the very basics regarding GRADE, and what you need to do after completing a guideline. It will also signpost you to other courses organised by Guideline International Network.

The course includes comprehensive PPT slides and bespoke video presentations. The combined material has a total duration of approximately 30 minutes. The estimated time needed to complete the course, including the final assessment, is 45 minutes.

Target audience

This course is suitable for gastroenterologists in training, but is also appropriate for physicians in other disciplines and surgeons , as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in developing guidelines.

Enrol Part 2: How to develop guidelines - Part 2

Event

How to develop guidelines - Part 1

Topics

Education & Training

Accreditation status

accredited

Duration

45 minutes

Published

2024

More Like This:

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

TWO ROADS TO OBLITERATION: EUS-GUIDED COILING OF GASTRIC VARICES -DIRECT VARICEAL SAC VERSUS FEEDER VESSEL (ARAKAWA-1) APPROACH

shivam kalia shivam kalia

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Stuart McDonald Stuart McDonald, Simon Leedham

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

DISSECTING THE HINDRANCE OF HEDGEHOG PATHWAY IN INTRAHEPATIC CHOLANGIOCARCINOMA: A STEP TOWARDS TARGETED THERAPY

Guido Carpino Guido Carpino, Vincenzo Cardinale, Domenico Alvaro, Eugenio Gaudio, Bruno Botta, Teresa De Luca, MATTEO FRANCHITTO, Chiara Di Meo, Deborah Quaglio, Lucia Di Marcotullio, Paola Infante, Savino Paradiso

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

How to develop guidelines - Part 1

How to develop guidelines - Part 1

Ana Dugic Ana Dugic, Adele Sayers, Yasuko Maeda

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.